CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma. Read more about CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma.
ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A. Read more about ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.
Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response. Read more about Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response.
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. Read more about Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression. Read more about The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression.
Challenges in identifying cancer genes by analysis of exome sequencing data. Read more about Challenges in identifying cancer genes by analysis of exome sequencing data.
αE-catenin inhibits YAP/TAZ activity to regulate signalling centre formation during tooth development. Read more about αE-catenin inhibits YAP/TAZ activity to regulate signalling centre formation during tooth development.
Human islets contain four distinct subtypes of β cells. Read more about Human islets contain four distinct subtypes of β cells.
Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity. Read more about Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity.
Microfluidic single-cell transcriptional analysis rationally identifies novel surface marker profiles to enhance cell-based therapies. Read more about Microfluidic single-cell transcriptional analysis rationally identifies novel surface marker profiles to enhance cell-based therapies.
